PCNL creates a direct tract into the kidney to remove large stones
A needle tract is developed through the back into the collecting system, allowing a nephroscope and fragmentation tools to remove stone material.
Positioning, tract number and size, intrarenal anatomy and bacterial risk are tailored to stone complexity and patient factors.
A negative bladder culture does not always exclude bacteria inside an obstructed kidney or infected stone; the team should plan antibiotics and drainage accordingly.
Who may be considered?
Specialist review may help when the diagnosis, symptoms and previous treatment create a focused question about percutaneous nephrolithotomy.
- A staghorn or other large kidney stone.
- Stone burden unlikely to clear reliably with shock waves or ureteroscopy.
- A hard or anatomically inaccessible stone after failed treatment.
- A patient with acceptable bleeding and anesthesia risk.
What the specialist team must confirm
Review thin-slice CT, collecting-system anatomy, stone volume and density, urine cultures, previous infection, kidney function, hemoglobin, coagulation, body habitus and prior renal surgery.
Key points for this treatment
From access mapping to residual-stone review
Large stones may still require more than one tract, staged endoscopy or combined techniques despite a strong clearance goal.
Bleeding, drainage and infection guide early recovery
A nephrostomy tube or ureteral stent may be used temporarily. Blood counts, urine output, pain, fever and imaging are monitored.
Later imaging measures true clearance. Stone analysis and metabolic evaluation address recurrence risk, which remains after technically successful surgery.
Risks, limits and realistic expectations
Risks include bleeding and transfusion, sepsis, kidney or adjacent-organ injury, urine leak, pleural complication, residual stones, repeat access and rare loss of kidney function.
Fever, shortness of breath, faintness, worsening flank swelling, heavy bleeding or reduced urine output requires urgent local review.